Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune Cells
- 11 December 2022
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 35 (3) , e2208277
Abstract
Design of effective nanomedicines to modulate multiple immune cells to overcome the immune‐suppressive tumor microenvironment is desirable to improve the overall poor clinical outcomes of immunotherapy. Herein, a nanomedicine platform is reported based on chemotherapeutic drug doxorubicin (DOX)‐loaded phosphorus dendron micelles (M‐G1‐TBPNa@DOX, TBP, tyramine bearing two dimethylphosphonate) with inherent immunomodulatory activity for synergistic tumor chemoimmunotherapy. The M‐G1‐TBPNa@DOX micelles with good stability and a mean particle size of 86.4 nm can deliver DOX to solid tumors to induce significant tumor cell apoptosis and immunogenic cell death (ICD). With the demonstrated intrinsic activity of M‐G1‐TBPNa that can promote the proliferation of natural killer (NK) cells, the ICD‐resulted maturation of dendritic cells of the DOX‐loaded micelles, and the combination of anti‐PD‐L1 antibody, the synergistic modulation of multiple immune cells through NK cell proliferation, recruitment of tumor‐infiltrating NK cells and cytotoxic T cells, and decrease of regulatory T cells for effective tumor chemoimmunotherapy with strong antitumor immunity and immune memory effect for effective prevention of lung metastasis are demonstrated. The developed phosphorous dendron micelles may hold great promise to be used as an advanced nanomedicine formulation for synergistic modulation of multiple immune cells through NK cell proliferation for effective chemoimmunotherapy of different tumor types.Keywords
Funding Information
- National Natural Science Foundation of China (81761148028, 22150410324)
- Science and Technology Commission of Shanghai Municipality (21490711500, 20DZ2254900)
This publication has 60 references indexed in Scilit:
- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapyNature Nanotechnology, 2017
- Poly(phosphorhydrazone) dendrimers: yin and yang of monocyte activation for human NK cell amplification applied to immunotherapy against multiple myelomaNanomedicine: Nanotechnology, Biology and Medicine, 2016
- The key role of the scaffold on the efficiency of dendrimer nanodrugsNature Communications, 2015
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- A Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental ArthritisScience Translational Medicine, 2011
- Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapyJournal of Translational Medicine, 2009
- Multiplication of Human Natural Killer Cells by Nanosized Phosphonate‐Capped DendrimersAngewandte Chemie International Edition, 2007
- Design of phosphorylated dendritic architectures to promote human monocyte activationThe FASEB Journal, 2006
- Living Alternating Copolymerization of N-Alkylaziridines and Carbon Monoxide as a Route for Synthesis of Poly-β-peptoidsJournal of the American Chemical Society, 2002
- MALDI TOF Mass Spectrometry for the Characterization of Phosphorus-Containing Dendrimers. Scope and LimitationsAnalytical Chemistry, 2000